CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World SettingBradley D. Hunter, Manali Kamdar, Abu‐Sayeef Mirza et al.|Transplantation and Cellular Therapy|2025Cited by 3